{
    "Case ID": "006519",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "valid if meets novelty, inventiveness, sufficiency criteria",
                "selection patents require proving special advantages over prior art"
            ],
            "cause_of_action": [
                "anticipation",
                "obviousness",
                "double patenting",
                "misrepresentation"
            ],
            "evidence_presented": [
                "extensive research to identify olanzapine's unique properties"
            ],
            "relevant_statute": [
                "Canadian Patent Law"
            ],
            "decision_reasoning": [
                "Apotex failed to prove invalidity on any grounds"
            ],
            "result_of_case": [
                "Lilly's application granted",
                "'113 Patent is valid"
            ],
            "procedure_followed": [
                "NOC proceedings",
                "detailed affidavits",
                "expert testimonies",
                "legal arguments focusing on patent validity"
            ]
        }
    ]
}